Én procent af patienterne behandlet med REYATAZ oplevede samtidig grad 3- 4 ALAT/ ASAT og grad 3- 4 forhøjelser af total bilirubin.
One percent of patients treated with REYATAZ experienced concurrent Grade 3-4 ALT/ AST and Grade 3-4 total bilirubin elevations.